Association between High Platelet Reactivity Following Dual Antiplatelet Therapy and Ischemic Events in Japanese Patients with Coronary Artery Disease Undergoing Stent Implantation-Reference-Cited by-同舟云学术

Association between High Platelet Reactivity Following Dual Antiplatelet Therapy and Ischemic Events in Japanese Patients with Coronary Artery Disease Undergoing Stent Implantation

Published:2020-01-01 Issue:1 Volume:27 Page:13-24
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Nishikawa Masakatsu¹,Takeda Yoshihiro²,Isomura Naoei³,Tanigawa Takashi⁴,Nanasato Mamoru⁵,Tsukahara Kengo⁶,Kimura Kazuo⁶,Takayama Tadateru⁷,Hirayama Atsushi⁷,Kato Masafumi⁸,Nishikawa Hideo⁸,Nishimura Yuki¹,Isshiki Takaaki⁹,Yokoi Hiroyoshi¹⁰¹¹,

Affiliation:

1. Clinical Research Support Center, Mie University Hospital

2. Department of Cardiology, Rinku General Medical Center

3. Department of Cardiology, Showa University Northern Yokohama Hospital

4. Department of Cardiology, Mie University Faculty of Medicine

5. Cardiovascular Center, Japanese Red Cross Nagoya Daini Hospital

6. Yokohama City University Medical Center

7. Department of Cardiovascular Medicine, Nihon University Itabashi Hospital

8. Mie Heart Center

9. Division of Cardiology, Teikyo University Hospital

10. Cardiovascular Center, Fukuoka Sanno Hospital

11. Division of Cardiology, Kokura Memorial Hospital

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/27/1/27_48934/_pdf

Reference29 articles.

1. 1) Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, Granger CB, Lange RA, Mack MJ, Mauri L, Mehran R, Mukherjee D, Newby LK, O’Gara PT, Sabatine MS, Smith PK, Smith SC Jr.: 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery. Circulation, 2016; 134: e123-155

2. 2) Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, Jüni P, Kastrati A, Kolh P, Mauri L, Montalescot G, Neumann FJ, Petricevic M, Roffi M, Steg PG, Windecker S, Zamorano JL, Levine GN; ESC Scientific Document Group; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies: 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J, 2018; 39: 213-260

3. 3) Mauri L, Kereiakes DJ, Yeh RW, Driscoll-Shempp P, Cutlip DE, Steg PG, Normand SL, Braunwald E, Wiviott SD, Cohen DJ, Holmes Jr DR: Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. NEJM, 2014; 371: 2155-2166

4. 4) Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J: Prasugrel versus clopidogrel in patients with acute coronary syndromes. NEJM, 2007; 357: 2001-2015

5. 5) Kazui M, Nishiya Y, Ishizuka T, Hagihara K, Farid NA, Okazaki O, Ikeda T, Kurihara A: Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite. Drug Metab Dispos, 2010; 38: 92-99

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex Differences in Bleeding Risk Associated With Antithrombotic Therapy Following Percutaneous Coronary Intervention;Circulation Reports;2024-04-10

2. Impact of Platelet Hyperreactivity and Diabetes Mellitus on Ischemic Stroke Recurrence: A Single-Center Cohort Clinical Study;International Journal of General Medicine;2024-03

3. Prognostic Implication of Platelet Reactivity According to Left Ventricular Systolic Dysfunction Status in Patients Treated With Drug-Eluting Stent Implantation: Analysis of the PTRG-DES Consortium;Journal of Korean Medical Science;2024

4. High On-Treatment Platelet Reactivity: Aspirin versus Clopidogrel;Pharmacology;2022-12-02

5. Current and Future Insights for Optimizing Antithrombotic Therapy to Reduce the Burden of Cardiovascular Ischemic Events in Patients with Acute Coronary Syndrome;Journal of Clinical Medicine;2022-09-23